Latest fallopian tube cancer Stories
CALGARY, March 3, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
CALGARY, March 2, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
Study Failed to Meet Secondary Endpoint of Overall Survival THOUSAND OAKS, Calif., Nov.
Reportbuyer.com just published a new market research report:
Prophylactic salpingo-oophorectomyâ€”removal of the ovaries and fallopian tubes--reduces the relative risk of breast cancer by approximately 50 percent and the risk of ovarian and fallopian tube cancer by approximately 80 percent in women who carry a mutation in the BRCA1 or BRCA2 gene, researchers report in the January 13 online issue of the Journal of the National Cancer Institute.
By Akyuz, Aygul Guvenc, Gulten; Ustunsoz, Ayfer; Kaya, Tulay Purpose: To describe the experiences of Turkish women with gynecologic cancer and their partners. Design and Methods: Qualitative research using a descriptive phenomenological approach.
- The parings of haberdine; also, any kind of fragments.